A Prospective Study of Neonates with Persistent Pulmonary Hypertension of the Newborn: Prevalence, Clinical Outcomes, and Risk Factors

Document Type : Original Article

Authors

1 Department of Pediatric Neonatology, Bahrami Children’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

2 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

4 Department of Pediatric Cardiology, Bahrami Children’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

5 Department of Pediatric Hematology and Oncology, Bahrami Children’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Persistent pulmonary hypertension of the newborn (PPHN) is caused by the inability of the pulmonary arteries to dilate at birth, which leads to severe hypoxemia. Several risk factors have been identified in association with its occurrence and prognosis. The present study aimed to determine the incidence of PPHN, describe neonates’ characteristics, and evaluate the etiology, as well as mortality risk factors in newborns hospitalized due to PPHN at Bahrami Children’s Hospital, Tehran, Iran, from 2017 to 2020.
Methods: A total of 49 neonates were included in the present study. The PPHN diagnosis was based on clinical criteria and echocardiography provided by neonatologists. Therefore, a complete history, physical examination, and laboratory data were gathered. Afterward, PPHN etiology was determined, and the patients were followed up for six months. Finally, PPHN prevalence was calculated and probable risk factors for its complications were investigated by using logistic regression analysis.
Results: The findings revealed that the prevalence of PPHN was 3.5% in the center under study, and the mortality rate, as well as complete recovery, were 24.5% and 63%, respectively. It was also found that factors, such as male gender, abnormal Apgar score at birth, and cesarean delivery, were high in a percentage of PPHN patients; however, they were not associated with PPHN mortality and morbidity. The only variable that had a significant association with mortality and morbidity was an abnormal white blood cell count.
Conclusion: The need for inotropic support was associated with poor outcomes. From the aspect of etiology, there exists higher mortality rates, complications, and poor prognosis among PPHN patients with underdevelopment, compared to the ones with maldevelopment.
 
 

Keywords

References

  1. Abdel Mohsen AH, Amin AS. Risk factors and outcomes of persistent pulmonary hypertension of the newborn in neonatal intensive care unit of Al-minya university hospital in egypt. J Clin Neonatol. 2013;2(2):78-82.
  2. Abman SH. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology 2007;91(1661-7800 (Print)):283–90.
  3. Nair J, Lakshminrusimha S. Update on PPHN: mechanisms and treatment. Semin. Perinatol. 2014;38(2):78-91.
  4. Puthiyachirakkal M, Mhanna MJ. Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review. Front Pediatr. 2013;1:23.
  5. Mandell EA-O, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021;56(3):661-9.
  6. Singh Y, Lakshminrusimha S. Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn. Clin Perinatol. 2021;48(3):595-618.
  7. Kumar VH, Hutchison AA, Lakshminrusimha S, Morin FC, Wynn RJ, Ryan RM. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol. 2007;27(4):214-9.
  8. Abman SH. Neonatal pulmonary hypertension: a physiologic approach to treatment. Pediatr Pulmonol Suppl. 2004(1054-187X (Print)):127-8.
  9. Latini G, Del Vecchio A Fau - De Felice C, De Felice C Fau - Verrotti A, Verrotti A Fau - Bossone E, Bossone E. Persistent pulmonary hypertension of the newborn: therapeutical approach. Mini Rev Med Chem. 2008;8(14):1507-13.
  10. Greenough A, Khetriwal B. Pulmonary hypertension in the newborn. Paediatr Respir Rev. 2005;
    6(2):111-6.
  11. Ambalavanan N, Aschner JL. Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants. J Perinatol. 2016;36(2):S20-S7.
  12. Konduri GG. New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol. 2004;31(3):591-611.
  13. Mathew B, Lakshminrusimha S. Persistent Pulmonary Hypertension in the Newborn. Children(basel). 2017;4(8):63-74.
  14. Ostrea EM, Villanueva-Uy Et Fau - Natarajan G, Natarajan G Fau - Uy HG, Uy HG. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management. Paediatr. 2006;8(3):179-88.
  15. Hernández-Díaz S, Van Marter Lj Fau - Werler MM, Werler Mm Fau - Louik C, Louik C Fau - Mitchell AA, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007;
    120(2):272-82.
  16. Murphy Jd Fau - Rabinovitch M, Rabinovitch M Fau - Goldstein JD, Goldstein Jd Fau - Reid LM, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr. 1981;98(6):962-7.
  17. Dhillon R. The management of neonatal pulmonary hypertension. BMJ Fetal Neonatal Ed. 2012;
    97(1468-2052 (Electronic)):223-8.
  18. Martinho S, Adão R, Leite-Moreira AF, Brás-Silva C. Persistent Pulmonary Hypertension of the Newborn: Pathophysiological mechanisms and novel therapeutic approaches. Front Pediatr. 2020;8:342.
  19. Chimenz R, Cannavò L, Gasbarro A, Nascimben F, Sestito S, Rizzuti L, et al. PPHN and oxidative stress: a review of literature. J Biol Regul Homeost Agents. 2020;34(4 Suppl. 2):79-83.
  20. Rocha G, Baptista Mj Fau - Guimarães H, Guimarães H. Persistent pulmonary hypertension of non cardiac cause in a neonatal intensive care unit. Pulm Med. 2012;2012:818971.
  21. Roofthooft MT, Elema A Fau - Bergman KA, Bergman Ka Fau Berger RMF, Berger RM. Patient characteristics in persistent pulmonary hypertension of the newborn. Pulm Med. 2011;2011:858154.
  22. Teng R-J, Wu T-J. Persistent pulmonary hypertension of the newborn. J Formos Med Assoc. 2013;112(4):177-84.
  23. Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, Partridge JC, Rogers EE, Keller RL. Persistent pulmonary hypertension of the newborn in late preterm and term infants in California. Pediatrics. 2017;
    139(1):e20161165.
  24. Nakanishi H, Suenaga H, Uchiyama A, Kusuda S. Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study. BMJ Fetal Neonatal Ed. 2018;103(6):554-61.
  25. Mydam J, Zidan M Fau - Chouthai NS, Chouthai NS. A comprehensive study of clinical biomarkers, use of inotropic medications and fluid resuscitation in newborns with persistent pulmonary hypertension. Pediatr Cardiol. 2015;36(1):233-9.
  26. Harerimana I, Ballot D, Cooper P. Retrospective review of neonates with persistent pulmonary hypertension of the newborn at charlotte maxeke johannesburg academic hospital. S Afr J Child Health. 2018;12:29-35.
  27. Nakwan N, Jain S, Kumar K, Hosono S, Hammoud M, Elsayed YY, et al. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Matern.-Fetal Neonatal Med. 2018;33(12):2032-7.
  28. Razzaq A, Iqbal Quddusi A, Nizami N. Risk factors and mortality among newborns with persistent pulmonary hypertension. Pak J Med Sci. 2013;
    29(5):1099-104.
  29. Bakheet M, Metwalley K, Sadek A. Evaluation of persistent pulmonary hypertension of the newborn (PPHN) in Upper Egypt. Gaz Egypt Paediatr Assoc. 2013;61:96–9.
  30. Wilson KL, Zelig Cm Fau - Harvey JP, Harvey Jp Fau - Cunningham BS, Cunningham Bs Fau - Dolinsky BM, Dolinsky Bm Fau - Napolitano PG, Napolitano PG. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol. 2011;28(1):19-24.
  31. Visser M, Bouter Lm Fau - McQuillan GM, McQuillan Gm Fau - Wener MH, Wener Mh Fau - Harris TB, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;
    282(22):2131-5.
Iranian Journal of Neonatology
Volume 13, Issue 2
April 2022
Pages 112-119

Files

Share

How to cite

Statistics